Class information for: |
Basic class information |
Class id | #P | Avg. number of references |
Database coverage of references |
---|---|---|---|
6598 | 1465 | 33.7 | 72% |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Cluster id | Level | Cluster label | #P |
---|---|---|---|
1 | 4 | ECONOMICS//EDUCATION & EDUCATIONAL RESEARCH//PSYCHOL | 3876184 |
341 | 3 | SMOKING CESSATION//SMOKING//TOBACCO CONTROL | 36872 |
18 | 2 | SMOKING CESSATION//SMOKING//TOBACCO CONTROL | 36872 |
6598 | 1 | CYP2A6//COTININE//CYP2A5 | 1465 |
Terms with highest relevance score |
rank | Term | termType | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|---|
1 | CYP2A6 | authKW | 1280019 | 8% | 56% | 110 |
2 | COTININE | authKW | 952395 | 13% | 23% | 197 |
3 | CYP2A5 | authKW | 380766 | 2% | 70% | 26 |
4 | NICOTINE METABOLISM | authKW | 372909 | 2% | 62% | 29 |
5 | TRANS 3 HYDROXYCOTININE | authKW | 297725 | 1% | 71% | 20 |
6 | CYP2A13 | authKW | 281352 | 1% | 75% | 18 |
7 | CLIN PHARMACOL EXPT THER EUT | address | 201851 | 3% | 21% | 47 |
8 | COUMARIN 7 HYDROXYLASE | authKW | 187568 | 1% | 75% | 12 |
9 | NICOTINE METABOLITES | authKW | 187562 | 1% | 60% | 15 |
10 | NICOTINE | authKW | 182769 | 18% | 3% | 262 |
Web of Science journal categories |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | Pharmacology & Pharmacy | 4704 | 34% | 0% | 499 |
2 | Chemistry, Analytical | 2540 | 19% | 0% | 276 |
3 | Toxicology | 2110 | 12% | 0% | 175 |
4 | Substance Abuse | 1414 | 5% | 0% | 70 |
5 | Biochemical Research Methods | 1057 | 10% | 0% | 143 |
6 | Medical Laboratory Technology | 766 | 4% | 0% | 59 |
7 | Public, Environmental & Occupational Health | 637 | 10% | 0% | 143 |
8 | Chemistry, Medicinal | 142 | 4% | 0% | 54 |
9 | Oncology | 75 | 6% | 0% | 87 |
10 | Genetics & Heredity | 54 | 4% | 0% | 59 |
Address terms |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | CLIN PHARMACOL EXPT THER EUT | 201851 | 3% | 21% | 47 |
2 | CLIN PHARMACOL EXPT THER EUTMED SERV | 65126 | 0% | 63% | 5 |
3 | WORLDWIDE SCI AFFAIRS | 46892 | 0% | 75% | 3 |
4 | MECANISMES ACT NICOTIANEES | 41683 | 0% | 100% | 2 |
5 | CAMPBELL FAMILY MENTAL HLTH | 40789 | 2% | 8% | 26 |
6 | ADDICT MENTAL HLTH | 35471 | 4% | 3% | 56 |
7 | PHARMACOBIODYNAM | 35156 | 1% | 19% | 9 |
8 | BIO FOOD CHEM | 27787 | 0% | 67% | 2 |
9 | MED SERVSAN FRANCISCO GEN HOSPMED | 27787 | 0% | 67% | 2 |
10 | SAN FRANCISCO GEN HOSP MED | 27416 | 0% | 26% | 5 |
Journals |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | DRUG METABOLISM AND DISPOSITION | 14724 | 5% | 1% | 73 |
2 | NICOTINE & TOBACCO RESEARCH | 11713 | 3% | 2% | 37 |
3 | PHARMACOGENETICS | 7110 | 1% | 2% | 18 |
4 | PHARMACOGENETICS AND GENOMICS | 5283 | 1% | 2% | 17 |
5 | CLINICAL PHARMACOLOGY & THERAPEUTICS | 4846 | 3% | 1% | 37 |
6 | DRUG METABOLISM AND PHARMACOKINETICS | 2871 | 1% | 1% | 10 |
7 | JOURNAL OF CHROMATOGRAPHY-BIOMEDICAL APPLICATIONS | 2780 | 2% | 1% | 22 |
8 | JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES | 2322 | 3% | 0% | 37 |
9 | CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION | 2198 | 2% | 0% | 26 |
10 | XENOBIOTICA | 2120 | 1% | 1% | 20 |
Author Key Words |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | CYP2A6 | 1280019 | 8% | 56% | 110 | Search CYP2A6 | Search CYP2A6 |
2 | COTININE | 952395 | 13% | 23% | 197 | Search COTININE | Search COTININE |
3 | CYP2A5 | 380766 | 2% | 70% | 26 | Search CYP2A5 | Search CYP2A5 |
4 | NICOTINE METABOLISM | 372909 | 2% | 62% | 29 | Search NICOTINE+METABOLISM | Search NICOTINE+METABOLISM |
5 | TRANS 3 HYDROXYCOTININE | 297725 | 1% | 71% | 20 | Search TRANS+3+HYDROXYCOTININE | Search TRANS+3+HYDROXYCOTININE |
6 | CYP2A13 | 281352 | 1% | 75% | 18 | Search CYP2A13 | Search CYP2A13 |
7 | COUMARIN 7 HYDROXYLASE | 187568 | 1% | 75% | 12 | Search COUMARIN+7+HYDROXYLASE | Search COUMARIN+7+HYDROXYLASE |
8 | NICOTINE METABOLITES | 187562 | 1% | 60% | 15 | Search NICOTINE+METABOLITES | Search NICOTINE+METABOLITES |
9 | NICOTINE | 182769 | 18% | 3% | 262 | Search NICOTINE | Search NICOTINE |
10 | NICOTINE METABOLITE RATIO | 168815 | 1% | 90% | 9 | Search NICOTINE+METABOLITE+RATIO | Search NICOTINE+METABOLITE+RATIO |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Rank | Reference | # ref. in cl. |
Shr. of ref. in cl. |
Citations |
---|---|---|---|---|
1 | HUKKANEN, J , JACOB, P , BENOWITZ, NL , (2005) METABOLISM AND DISPOSITION KINETICS OF NICOTINE.PHARMACOLOGICAL REVIEWS. VOL. 57. ISSUE 1. P. 79 -115 | 160 | 43% | 626 |
2 | MWENIFIUMBO, JC , TYNDALE, RF , (2007) GENETIC VARIABILITY IN CYP2A6 AND THE PHARMACOKINETICS OF NICOTINE.PHARMACOGENOMICS. VOL. 8. ISSUE 10. P. 1385 -1402 | 90 | 76% | 57 |
3 | ROSSINI, A , SIMAO, TD , ALBANO, RM , PINTO, LFR , (2008) CYP2A6 POLYMORPHISMS AND RISK FOR TOBACCO-RELATED CANCERS.PHARMACOGENOMICS. VOL. 9. ISSUE 11. P. 1737-1752 | 81 | 79% | 31 |
4 | ALLENBY, CE , BOYLAN, KA , LERMAN, C , FALCONE, M , (2016) PRECISION MEDICINE FOR TOBACCO DEPENDENCE: DEVELOPMENT AND VALIDATION OF THE NICOTINE METABOLITE RATIO.JOURNAL OF NEUROIMMUNE PHARMACOLOGY. VOL. 11. ISSUE 3. P. 471 -483 | 66 | 69% | 2 |
5 | ABU-BAKAR, A , HAKKOLA, J , JUVONEN, R , RAHNASTO-RILLA, M , RAUNIO, H , LANG, MA , (2013) FUNCTION AND REGULATION OF THE CYP2A5/CYP2A6 GENES IN RESPONSE TO TOXIC INSULTS IN THE LIVER.CURRENT DRUG METABOLISM. VOL. 14. ISSUE 1. P. 137-150 | 93 | 56% | 14 |
6 | DI, YM , CHOW, VDW , YANG, LP , ZHOU, SF , (2009) STRUCTURE, FUNCTION, REGULATION AND POLYMORPHISM OF HUMAN CYTOCHROME P450 2A6.CURRENT DRUG METABOLISM. VOL. 10. ISSUE 7. P. 754-780 | 111 | 45% | 51 |
7 | NAKAJIMA, M , (2007) SMOKING BEHAVIOR AND RELATED CANCERS: THE ROLE OF CYP2A6 POLYMORPHISMS.CURRENT OPINION IN MOLECULAR THERAPEUTICS. VOL. 9. ISSUE 6. P. 538-544 | 58 | 81% | 12 |
8 | TRICKER, AR , (2003) NICOTINE METABOLISM, HUMAN DRUG METABOLISM POLYMORPHISMS, AND SMOKING BEHAVIOUR.TOXICOLOGY. VOL. 183. ISSUE 1-3. P. 151 -173 | 75 | 61% | 71 |
9 | WASSENAAR, CA , ZHOU, Q , TYNDALE, RF , (2016) CYP2A6 GENOTYPING METHODS AND STRATEGIES USING REAL-TIME AND END POINT PCR PLATFORMS.PHARMACOGENOMICS. VOL. 17. ISSUE 2. P. 147 -162 | 41 | 84% | 0 |
10 | CHENOWETH, MJ , NOVALEN, M , HAWK, LW , SCHNOLL, RA , GEORGE, TP , CINCIRIPINI, PM , LERMAN, C , TYNDALE, RF , (2014) KNOWN AND NOVEL SOURCES OF VARIABILITY IN THE NICOTINE METABOLITE RATIO IN A LARGE SAMPLE OF TREATMENT-SEEKING SMOKERS.CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION. VOL. 23. ISSUE 9. P. 1773 -1782 | 41 | 77% | 11 |
Classes with closest relation at Level 1 |